Related Experiment Video
Updated: Oct 11, 2025

Generation of Murine Cardiac Pacemaker Cell Aggregates Based on ES-Cell-Programming in Combination with Myh6-Promoter-Selection
Published on: February 17, 2015
Molecular Remodeling of Cardiac Sinus Node Associated with Acute Chagas Disease Myocarditis
Héctor O Rodríguez-Angulo1,2, Diana Colombet-Naranjo1, María C Maza3,4
1Instituto Venezolano de Investigaciones Científicas, Caracas 1020A, Venezuela.
Insights
Chagas disease may cause sudden cardiac death by increasing HCN4 channel expression. Ivabradine, a drug targeting HCN4, showed complex effects on arrhythmias in mice, suggesting cautious use and potential diagnostic value.
Area of Science:
- Cardiology
- Molecular Biology
- Parasitology
Background:
- Chagas disease, prevalent in Latin America, now has global distribution due to migration.
- Sudden cardiac death can occur in Chagas disease patients, even without apparent cardiac structural disease.
- The role of HCN4 channels in Chagasic arrhythmias remains unclear.
Purpose of the Study:
- To investigate the role of HCN4 channels in Chagas disease-related arrhythmias.
- To assess the effects of ivabradine, an HCN4 channel blocker, on cardiac function and arrhythmias in a mouse model of Chagas disease.
Main Methods:
- Administration of ivabradine (single dose and continuous treatment) to mice challenged with isoproterenol.
- Electrocardiographic monitoring (QTc, QRS, P-wave amplitude) and arrhythmia assessment.
- Analysis of HCN4 channel expression in cardiac tissue.
Main Results:
- Single-dose ivabradine enlarged QTc and QRS intervals, increased P-wave amplitude, and induced arrhythmias.
- Continuous ivabradine treatment modified P-wave morphology, induced supraventricular arrhythmias, but improved repolarization.
- High HCN4 channel expression was observed in auricular and ventricular tissue of infected mice.
Conclusions:
- Overexpression of HCN4 channels may contribute to supraventricular arrhythmias in acute Chagas disease, potentially leading to ivabradine over-response.
- Ivabradine should be used cautiously in Chagas disease patients.
- HCN4 channel overexpression may serve as an indicator for heart failure and sudden death risk in Chagas disease.
Abstract:
Chagas disease principally affects Latin-American people, but it currently has worldwide distribution due to migration. Death among those with Chagas disease can occur suddenly and without warning, even in those who may not have evidence of clinical or structural cardiac disease and who are younger than 60 years old. HCN4 channels, one of the principal elements responsible for pacemaker currents, are associated with cardiac fetal reprogramming and supraventricular and ventricular arrhythmias, but their role in chagasic arrhythmias is not clear. We found that a single-dose administration of ivabradine, which blocks HCN4, caused QTc and QRS enlargement and an increase in P-wave amplitude and was associated with ventricular and supraventricular arrhythmias in mice challenged with isoproterenol, a chronotropic/ionotropic positive agent. Continuous treatment with ivabradine did not alter the QTc interval, but P-wave morphology was deeply modified, generating supraventricular arrhythmias. In addition, we found that repolarization parameters improved with ivabradine treatment. These effects could have been caused by the high HCN4 expression observed in auricular and ventricular tissue in infected mice. Thus, we suggest, for the first time, that molecular remodeling by overexpression of HCN4 channels may be related to supraventricular arrhythmias in acute Chagas disease, causing ivabradine over-response. Thus, ivabradine treatment should be administered with caution, while HCN4 overexpression may be an indicator of heart failure and/or sudden death risk.
More Related Videos
09:20Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
06:40Impact of Intracardiac Neurons on Cardiac Electrophysiology and Arrhythmogenesis in an Ex Vivo Langendorff System
Published on: May 22, 2018
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Mechanism of Cardiac Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy